Cognitive dysfunction and anxious-impulsive personality traits are endophenotypes for drug dependence

American Journal of Psychiatry

Volumn 169, Issue 9, 2012, Pages 926-936

  Ersche, Karen D ^a,b,c,d   Turton, Abigail J ^a,b,c,d   Chamberlain, Samuel R ^a,b,c,d   Müller, Ulrich ^a,b,c,d   Bullmore, Edward T ^a,b,c,d   Robbins, Trevor W ^a,b,c,d  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UK   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

^d CAMBRIDGESHIRE AND PETERBOROUGH NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; COCAINE;

ADULT; AMPHETAMINE DEPENDENCE; ANXIOUS IMPULSIVE PERSONALITY TRAIT DISORDER; ARTICLE; ATTENTION; BRAIN FUNCTION; CLINICAL ARTICLE; COCAINE DEPENDENCE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG DEPENDENCE; ENDOPHENOTYPE; EXECUTIVE FUNCTION; FAMILY HISTORY; FEMALE; HUMAN; MALE; PERSONALITY DISORDER; PRIORITY JOURNAL; RISK ASSESSMENT; VISUAL MEMORY;

EID: 84865848478     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2012.11091421     Document Type: Article

References (75)

1. Nutt DJ, Robbins TW, Stimson GV, Ince M, Jackson ARW: Drugs and the Future: Brain Science, Addiction and Society. Oxford, UK, Elsevier, 2006
2. Nutt D, King LA, Saulsbury W, Blakemore C: Development of a rational scale to assess the harm of drugs of potential misuse. Lancet 2007; 369:1047-1053 (Pubitemid 46436128)
3. Merikangas KR, Stolar M, Stevens DE, Goulet J, Preisig MA, Fenton B, Zhang HP, O'Malley SS, Rounsaville BJ: Familial transmission of substance use disorders. Arch Gen Psychiatry 1998; 55:973-979 (Pubitemid 28506838)
4. Kendler KS, Jacobson KC, Prescott CA, Neale MC: Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am J Psychiatry 2003; 160:687-695 (Pubitemid 41079601)
5. Tyrfingsson T, Thorgeirsson TE, Geller F, Runarsdottir V, Hansdottir I, Bjornsdottir G, Wiste AK, Jonsdottir GA, Stefansson H, Gulcher JR, Oskarsson H, Gudbjartsson D, Stefansson K: Addictions and their familiality in Iceland. Ann N Y Acad Sci 2010; 1187: 208-217
6. Zucker RA: The developmental behavior genetics of drug involvement: overview and comments. Behav Genet 2006; 36: 616-625
7. Vanyukov MM, Kirisci L, Moss L, Tarter RE, Reynolds MD, Maher BS, Kirillova GP, Ridenour T, Clark DB: Measurement of the risk for substance use disorders: phenotypic and genetic analysis of an index of common liability. Behav Genet 2009; 39:233-244
8. Tsuang MT, Lyons MJ, Meyer JM, Doyle T, Eisen SA, Goldberg J, True W, Lin N, Toomey R, Eaves L: Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry 1998; 55:967-972 (Pubitemid 28506837)
9. Bierut LJ: Genetic vulnerability and susceptibility to substance dependence. Neuron 2011; 69:618-627
10. Gottesman II, Gould TD: The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003; 160:636-645 (Pubitemid 41079594)
11. Dalley JW, Cardinal RN, Robbins TW: Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev 2004; 28:771-784 (Pubitemid 39535871)
12. Goldstein RZ, Volkow ND: Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 2002; 159: 1642-1652
13. Fillmore MT, Rush CR: Impaired inhibitory control of behavior in chronic cocaine users. Drug Alcohol Depend 2002; 66: 265-273 (Pubitemid 34327862)
14. Monterosso JR, Aron AR, Cordova X, Xu J, London ED: Deficits in response inhibition associated with chronic methamphetamine abuse. Drug Alcohol Depend 2005; 79:273-277 (Pubitemid 40942119)
15. Ersche KD, Clark L, London M, Robbins TW, Sahakian BJ: Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacology 2006; 31:1036-1047
16. Ornstein TJ, Iddon JL, Baldacchino AM, Sahakian BJ, London M, Everitt BJ, Robbins TW: Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers. Neuropsychopharmacology 2000; 23:113-126 (Pubitemid 30406896)
17. Tomasi D, Goldstein RZ, Telang F, Maloney T, Alia-Klein N, Caparelli EC, Volkow ND: Widespread disruption in brain activation patterns to a working memory task during cocaine abstinence. Brain Res 2007; 1171:83-92 (Pubitemid 47404527)
18. Ersche KD, Roiser JP, Lucas M, Domenici E, Robbins TW, Bullmore ET: Peripheral biomarkers of cognitive response to dopamine receptor agonist treatment. Psychopharmacology (Berl) 2011; 214:779-789
19. Fernández-Serrano MJ, Pérez-García M, Schmidt Río-Valle J, Verdejo-García A: Neuropsychological consequences of alcohol and drug abuse on different components of executive functions. J Psychopharmacol 2010; 24:1317-1332
20. Gooding DC, Burroughs S, Boutros NN: Attentional deficits in cocaine-dependent patients: converging behavioral and electrophysiological evidence. Psychiatry Res 2008; 160:145-154
21. Ersche KD, Barnes A, Jones PS, Morein-Zamir S, Robbins TW, Bullmore ET: Abnormal structure of frontostriatal brain systems is associated with aspects of impulsivity and compulsivity in cocaine dependence. Brain 2011; 134:2013-2024
22. London ED, Berman SM, Voytek B, Simon SL, Mandelkern MA, Monterosso J, Thompson PM, Brody AL, Geaga JA, Hong MS, Hayashi KM, Rawson RA, Ling W: Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers. Biol Psychiatry 2005; 58:770-778 (Pubitemid 41677415)
23. Beveridge TJR, Smith HR, Daunais JB, Nader MA, Porrino LJ: Chronic cocaine self-administration is associated with altered functional activity in the temporal lobes of non human primates. Eur J Neurosci 2006; 23:3109-3118 (Pubitemid 43882891)
24. Beveridge TJR, Gill KE, Hanlon CA, Porrino LJ: Parallel studies of cocaine-related neural and cognitive impairment in humans and monkeys. Philos Trans R Soc Lond B Biol Sci 2008; 363:3257-3266
25. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK: Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. JAMA 1990; 264:2511-2518
26. Merikangas KR, Mehta RL, Molnar BE, Walters EE, Swendsen JD, Aguilar-Gaziola S, Bijl R, Borges G, Caraveo-Anduaga JJ, Dewit DJ, Kolody B, Vega WA, Wittchen HU, Kessler RC: Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology. Addict Behav 1998; 23:893-907 (Pubitemid 28443200)
27. Merikangas KR, Dierker LC, Szatmari P: Psychopathology among offspring of parents with substance abuse and/or anxiety disorders: a high-risk study. J Child Psychol Psychiatry 1998; 39:711-720 (Pubitemid 28339603)
28. Volkow ND: The reality of comorbidity: depression and drug abuse. Biol Psychiatry 2004; 56:714-717
29. Kosten TR, Markou A, Koob GF: Depression and stimulant dependence: neurobiology and pharmacotherapy. J Nerv Ment Dis 1998; 186:737-745 (Pubitemid 28564169)
30. Markou A, Kosten TR, Koob GF: Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology 1998; 18:135-174 (Pubitemid 28062580)
31. Hawkins JD, Catalano RF, Miller JY: Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: implications for substance abuse prevention. Psychol Bull 1992; 112:64-105
32. Fisher M, Crome I, Macleod J, Bloor R, Hickman M: Predictive factors for illicit drug use among young people: a literature review. Probation Journal 2007; 54:278-279
33. de Wit H: Impulsivity as a determinant and consequence of drug use: a review of underlying processes. Addict Biol 2009; 14:22-31
34. Meda SA, Stevens MC, Potenza MN, Pittman B, Gueorguieva R, Andrews MM, Thomas AD, Muska C, Hylton JL, Pearlson GD: Investigating the behavioral and self-report constructs of impulsivity domains using principal component analysis. Behav Pharmacol 2009; 20:390-399
35. Stephenson MT, Helme DW: Authoritative parenting and sensation seeking as predictors of adolescent cigarette and marijuana use. J Drug Educ 2006; 36:247-270 (Pubitemid 47105317)
36. Lawrance L, Rubinson L: Self-efficacy as a predictor of smoking behavior in young adolescents. Addict Behav 1986; 11:367-382 (Pubitemid 17179761)
37. Barkin SL, Smith KS, DuRant RH: Social skills and attitudes associated with substance use behaviors among young adolescents. J Adolesc Health 2002; 30:448-454 (Pubitemid 34606943)
38. Newcomb MD, Harlow LL: Life events and substance use among adolescents: mediating effects of perceived loss of control and meaninglessness in life. J Pers Soc Psychol 1986; 51:564-577
39. Ersche KD, Turton AJ, Croudace T, Stochl J: Who do you think is in control in addiction? a pilot study on drug-related locus of control beliefs. Addict Disord Their Treatment (Epub ahead of print, Jan 15, 2012)
40. Dielman TE, Campanelli PC, Shope JT, Butchart AT: Susceptibility to peer pressure, self-esteem, and health locus of control as correlates of adolescent substance abuse. Health Educ Q 1987; 14:207-221
41. Goldman D, Oroszi G, Ducci F: The genetics of addictions: uncovering the genes. Nat Rev Genet 2005; 6:521-532 (Pubitemid 40910429)
42. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-Patient Edition (SCID-I/NP). New York, New York State Psychiatric Institute, Biometrics Research, 2002
43. Franken IHA, Hendriksa VM, van den Brink W: Initial validation of two opiate craving questionnaires: the Obsessive Compulsive Drug Use Scale and the Desires for Drug Questionnaire. Addict Behav 2002; 27:675-685 (Pubitemid 34712049)
44. Gavin DR, Ross HE, Skinner HA: Diagnostic validity of the Drug Abuse Screening Test in the assessment of DSM-III drug disorders. Br J Addict 1989; 84:301-307 (Pubitemid 19123352)
45. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M: Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II. Addiction 1993; 88:791-804 (Pubitemid 23194530)
46. Menzies L, Achard S, Chamberlain SR, Fineberg N, Chen CH, del Campo N, Sahakian BJ, Robbins TW, Bullmore E: Neurocognitive endophenotypes of obsessive-compulsive disorder. Brain 2007; 130:3223-3236 (Pubitemid 350209066)
47. Hartlage S, Alloy LB, Vázquez C, Dykman B: Automatic and effortful processing in depression. Psychol Bull 1993; 113:247-278
48. Howell DC: Statistical Methods for Psychology. London, Duxbury Press, 1997
49. Bradley RG, Binder EB, Epstein MP, Tang Y, Nair HP, Liu W, Gillespie CF, Berg T, Evces M, Newport DJ, Stowe ZN, Heim CM, Nemeroff CB, Schwartz A, Cubells JF, Ressler KJ: Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Arch Gen Psychiatry 2008; 65:190-200 (Pubitemid 351214318)
50. Acheson A, Richard DM, Mathias CW, Dougherty DM: Adults with a family history of alcohol-related problems are more impulsive on measures of response initiation and response inhibition. Drug Alcohol Depend 2011; 117:198-203
51. Tarter RE, Kirisci L, Mezzich A, Cornelius JR, Pajer K, Vanyukov M, Gardner W, Blackson T, Clark D: Neurobehavioral disinhibition in childhood predicts early age at onset of substance use disorder. Am J Psychiatry 2003; 160:1078-1085 (Pubitemid 41070966)
52. Dawes MA, Tarter RE, Kirisci L: Behavioral self-regulation: correlates and 2-year follow-ups for boys at risk for substance abuse. Drug Alcohol Depend 1997; 45:165-176 (Pubitemid 27232155)
53. Nigg JT, Wong MM, Martel MM, Jester JM, Puttler LI, Glass JM, Adams KM, Fitzgerald HE, Zucker RA: Poor response inhibition as a predictor of problem drinking and illicit drug use in adolescents at risk for alcoholism and other substance use disorders. J Am Acad Child Adolesc Psychiatry 2006; 45:468-475 (Pubitemid 43675552)
54. Chambers RA, Taylor JR, Potenza MN: Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiatry 2003; 160:1041-1052 (Pubitemid 41070962)
55. Kalivas PW, Volkow ND: The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 2005; 162:1403-1413 (Pubitemid 41105554)
56. Ersche KD, Jones PS, Williams GB, Turton AJ, Robbins TW, Bullmore ET: Abnormal brain structure implicated in stimulant drug addiction. Science 2012; 335:601-604
57. Ersche KD, Turton AJ, Pradhan S, Bullmore ET, Robbins TW: Drug addiction endophenotypes: impulsive versus sensationseeking personality traits. Biol Psychiatry 2010; 68:770-773
58. Newman JP, Wallace JF: Diverse pathways to deficient self-regulation: implications for disinhibitory psychopathology in children. Clin Psychol Rev 1993; 13:699-720 (Pubitemid 24000667)
59. Whiteside SP, Lynam DR: The Five Factor Model and impulsivity: using a structural model of personality to understand impulsivity. Pers Individ Dif 2001; 30:669-689 (Pubitemid 33380663)
60. Casey BJ, Jones RM, Hare TA: The adolescent brain. Ann NY Acad Sci 2008; 1124:111-126 (Pubitemid 351506787)
61. Steinberg L: Cognitive and affective development in adolescence. Trends Cogn Sci 2005; 9:69-74
62. Lewis MD, Todd RM: The self-regulating brain: cortical-subcortical feedback and the development of intelligent action. Cogn Dev 2007; 22:406-430
63. Ernst M, Romeo RD, Andersen SL: Neurobiology of the development of motivated behaviors in adolescence: a window into a neural systems model. Pharmacol Biochem Behav 2009; 93:199-211
64. Mann M, Hosman CMH, Schaalma HP, de Vries NK: Self-esteem in a broad-spectrum approach for mental health promotion. Health Educ Res 2004; 19:357-372 (Pubitemid 38988383)
65. DiClimente CC: Self-efficacy and the addictive behaviours. J Soc Clin Psychol 1986; 4:302-315
66. Narvaez JCM, Magalhaes PVS, Trindade EK, Vieira DC, Kauer-Sant'Anna M, Gama CS, von Diemen L, Kapczinski NS, Kapczinski F: Childhood trauma, impulsivity, and executive functioning in crack cocaine users. Compr Psychiatry 2012; 53:238-244
67. Brodsky BS, Oquendo M, Ellis SP, Haas GL, Malone KM, Mann JJ: The relationship of childhood abuse to impulsivity and suicidal behavior in adults with major depression. Am J Psychiatry 2001; 158:1871-1877 (Pubitemid 33054781)
68. Roy A: Childhood trauma and impulsivity: possible relevance to suicidal behavior. Arch Suicide Res 2005; 9:147-151
69. Pechtel P, Pizzagalli DA: Effects of early life stress on cognitive and affective function: an integrated review of human literature. Psychopharmacology (Berl) 2011; 214:55-70
70. Verdejo-García A, Pérez-García M: Profile of executive deficits in cocaine and heroin polysubstance users: common and differential effects on separate executive components. Psychopharmacology (Berl) 2007; 190:517-530
71. Pace-Schott EF, Morgan PT, Malison RT, Hart CL, Edgar C, Walker M, Stickgold R: Cocaine users differ from normals on cognitive tasks which show poorer performance during drug abstinence. Am J Drug Alcohol Abuse 2008; 34:109-121
72. Woicik PA, Moeller SJ, Alia-Klein N, Maloney T, Lukasik TM, Yeliosof O, Wang GJ, Volkow ND, Goldstein RZ: The neuropsychology of cocaine addiction: recent cocaine use masks impairment. Neuropsychopharmacology 2008; 34:1112-1122
73. Kreek MJ, Koob GF: Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend 1998; 51:23-47 (Pubitemid 28353754)
74. Sinha R: How does stress increase risk of drug abuse and relapse? Psychopharmacology (Berl) 2001; 158:343-359
75. Lee ACH, Owen AM, Rogers RD, Sahakian BJ, Robbins TW: Utility of CANTAB in functional neuroimaging, in Functional Neuroimaging in Child Psychology. Edited by Ernst M, Rumsey J. Cambridge, UK, Cambridge University Press, 2000, pp 366-377